BioSpace News Archive

Biotech Beach

NEURELIS PRESENTS NOVEL, INVESTIGATIONAL ANALYSIS OF valtoco® (DIAZEPAM NASAL SPRAY) civ demonstrating increased time between seizure clusters AT THE 51st Child Neurology Society Annual Meeting

Neurelis, Inc., today announced findings from a novel, investigational analysis of the time between seizure clusters in pediatric patients using VALTOCO® (diazepam nasal spray).

October 13, 2022
·
8 min read
Business

Aptar Declares Quarterly Dividend - October 13, 2022

AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, declared a quarterly cash dividend of $0.38 per share.

October 13, 2022
·
2 min read
BioMidwest

ulrich Medical USA™ Receives 510(k) Clearance for Flux-C™ 3D Printed Porous Titanium Cervical Interbody Prior to NASS

ulrich medical USA, Inc., a privately held medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today announced the FDA has given 510(k) clearance of its Flux-C 3D printed porous titanium cervical interbody device.

October 13, 2022
·
1 min read
Business

Zoetis Declares Fourth Quarter 2022 Dividend

The Board of Directors of Zoetis Inc. has declared a dividend of $0.325 per share for the fourth quarter of 2022.

October 13, 2022
·
2 min read
Genetown

CANbridge-UMass Chan Medical School Gene Therapy Research in Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 29th Annual Congress

CANbridge Pharmaceuticals Inc. (HKEX:1228) announced that data from its gene therapy research agreement with the Horae Gene Therapy Center, at the UMass Chan Medical School, was presented at the 29th European Society of Gene and Cell Therapy Annual Congress in Edinburgh, Scotland, today.

October 13, 2022
·
5 min read
Fosun Pharma’s MSCI ESG Rating Upgraded to A

The world’s leading index company Morgan Stanley Capital International recently announced its latest annual Environmental, Social and Governance rating results.

October 13, 2022
·
5 min read
Policy

Prestige Biopharma Submitted Pre-BLA Type 4 Meeting Request to FDA for Herceptin Biosimilar

Prestige Biopharma Limited, a Singapore-based biopharmaceutical company, has submitted a request to the U.S. Food and Drug Administration for a pre-submission meeting to discuss the company’s planned Biologics License Application for its Herceptin Biosimilar, HD201.

October 13, 2022
·
1 min read